ABEO - CIK 0000318306
ABEONA THERAPEUTICS INC. (ABEO) reported net income of -$71.18M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$71.18M | -211.7% |
| FY 2024 | $63.73M | +17.6% |
| FY 2023 | $54.19M | +236.5% |
| FY 2022 | -$39.70M | +53.3% |
| FY 2021 | -$84.94M | -0.8% |
| FY 2020 | -$84.23M | -10.4% |
| FY 2019 | -$76.28M | -34.6% |
| FY 2018 | -$56.67M | -107.4% |
| FY 2017 |
ABEONA THERAPEUTICS INC. (ABEO) reported net income of -$71.18M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, ABEONA THERAPEUTICS INC.'s net income declined from -$2.53M to -$71.18M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$27.32M |
| -24.9% |
| FY 2016 | -$21.87M | -50.6% |
| FY 2015 | -$14.53M | +45.8% |
| FY 2014 | -$26.78M | -701.9% |
| FY 2013 | $4.45M | +142.2% |
| FY 2012 | -$10.53M | -316.0% |
| FY 2011 | -$2.53M | - |